References
- Claeson G., Aurell L., Karlsson G., Friberger P. Substrate structure and activity relationships. Progress in Chemical Fibrinolysis and Thrombolysis, J. Davidson. Raven Press, N.Y., Vol. III, In press
- Collen D. Plasminogen and prothrombin metabolism in man. Thesis, University of Leuven, Belgium 1974
- Collen D., de Cock F., Verstraete M. Immunochemical distinction between antiplasmin and α1-antitrypsin. Thromb. Res. 1975; 7: 245
- Edy J., Collen D., Verstraete M. Evidence for a functionally important plasmin inhibitor in human plasma, different from α2-macroblogulin, α1-antitrypsin and antithrombin III. Abstracts from Vth Congress Intern. Soc. Thromb. Haemostas. Paris 1975; 486
- Edy J., de Cock F., Collen D. Inhibition of plasmin by normal and antiplasmin depleted plasma. Thromb. Res. 1975; 7: 245
- Fagerhol M. K., Abildgaard U. Immunological studies on human antithrombin III: Influence of age, sex and use of oral contraceptives on serum concentration. Scand. J. Haemat. 1970; 7: 10
- Gallimore M. J. Serum inhibitors of fibrinolysis. Brit. J. Haematol. 1975; 31: 217
- Ganrot P. O. Determination of α2-macroglobulin as trypsin-protein esterase. Clin. chim. Acta 1966; 14: 493
- Ganrot P. O. Inhibition of plasmin activity by α2-macroglobulin. Clin. chim. Acta 1967; 16: 328
- Ganrot P. O. Studies on serum protease inhibitors with special reference to α2-macroglobulin. Acta Univ. lund. 1967; 2
- Harpel P. C., Mosesson M. W., Cooper N. R. Studies on the structure and function of α2-macro-globulin and C1-inactivator. Proteases and Biological Control. Cold Spring Harbour Laboratory. 1975; 387
- Harper P. C., Rosenberg R. D. α2-Macroglobulin and antithrombin heparin cofactor: modulations of hemostatic and inflammatory reactions. Progress in Hemostasis and Thrombosis, T. H. Spaet. Grune and Stratton, New York 1976; Vol. 3: 145
- Hedner U. Studies on an inhibitor of plasminogen activation in human serum. Thromb. Diath. haemorhh. 1973; 30: 414
- Hedner U. Personal communication. 1976
- Highsmith R. F., Rosenberg R. D. The inhibition of human plasmin by human antithrombin-heparin cofactor. J. biol. Chem. 1974; 249: 4335
- Heimburger N. Proteinase inhibitors of human plasma—their properties and control functions. Proteases and Biological Control. Cold Spring Harbour Laboratory. 1975; 367
- Hochstrasser K., Bretzel G., Feuth H., Hilla W., Lempart K. The inter-α-trypsin inhibitor as precursor of the acid stable proteinase inhibitors in human serum and urine. Hoppe-Seyler's Z. physiol. Chem. 1976; 357: 153
- Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Analyt. Biochem. 1966; 15: 45
- Moroi M., Aoki N. Isolation and characterization of α2-plasmin inhibitor from human plasma. A novel proteinase inhibitor, which inhibits activator induced clot lysis. J. biol. Chem. 1976; 251: 5956
- Müllertz S. Molecular forms of plasmin and protease inhibitors in human fibrinolytic post mortem plasma. Scand. J. clin. Lab. Invest. 1972; 30: 369
- Müllertz S. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin. Biochem. J. 1974; 143: 273
- Nihlén J. E., Ganrot P. O. Plasmin, plasmin inhibitors and degradation products of fibrinogen in human serum during and after intravenous infusion of streptokinase. Scand. J. clin. Lab. Invest. 1967; 20: 113
- Ratnoff O. D., Pensky J., Ogston D., Naff G. B. The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor. J. exp. Med. 1969; 129: 315
- Sgouris J. T., Inman J. K., McCall K. B., Hyndman L. A., Anderson H. D. The preparation of human fibrinolysin (plasmin). Vox Sang. 1960; 5: 357